We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




An Inexpensive, Disposable Electrochemical Sensor for Detection of Bacteria in Chronic Wounds

By LabMedica International staff writers
Posted on 23 Feb 2016
A recent paper described an inexpensive, disposable electrochemical sensor for the detection of bacteria in chronic wounds.

Investigators at George Washington University (Washington DC, USA) developed the sensor under the auspices of the WE-HEAL Study, which focuses on the interplay of the host immune response and the wound bed microbiome in patients with chronic wounds.

The investigators pointed out that in the field of wound care there was a compelling need to develop rapid alternatives for bacterial identification in the clinical setting, where it generally takes over 24 hours to receive a positive identification. More...
Even new molecular and biochemical identification methods require an initial incubation period of several hours to obtain a sufficient number of cells prior to performing the analysis.

In the current study, the investigators the used an inexpensive, disposable electrochemical sensor to detect pyocyanin, a unique, redox-active quorum sensing molecule released by Pseudomonas aeruginosa, in wound fluid from patients with chronic wounds. By measuring the metabolite excreted by the cells, this electrochemical detection strategy eliminated sample preparation, required less than a minute to complete, and needed only 7.5 microliters of sample to complete the analysis.

The results obtained by the electrochemical technique were compared against 16S rRNA profiling using the 454 pyrosequencing method. Blind identification yielded nine correct matches, two false negatives, and three false positives, giving a sensitivity of 71% and specificity of 57% for detection of Pseudomonas.

"Being able to detect Pseudomonas and other infectious organisms at the time of the clinic visit will greatly enhance our ability to take care of patients," said senior author Dr. Victoria Shanmugam, director of the division of rheumatology at George Washington University. "We would not have to wait for culture results before making a decision about antibiotics, and this would allow us to better tailor therapies for our patients. Infections are a major challenge in medicine, and by using this probe, we were able to harness one of the unique molecules produced by bacteria to detect infection. We plan to continue to refine this testing method and hope to scale it up for detection of other bacteria and to optimize it for clinical use."

The method was described in the January 27, 2016, online edition of the journal Wound Repair and Regeneration.

Related Links:

George Washington University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
All-in-One Molecular System
AIO M160
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.